Published in

Royal Society of Chemistry, Biomaterials Science, 8(5), p. 1522-1525

DOI: 10.1039/c7bm00058h

Links

Tools

Export citation

Search in Google Scholar

Phospholipid-mimic oxaliplatin prodrug liposome for treatment of the metastatic triple negative breast cancer

Journal article published in 2017 by Bing Feng, Fangyuan Zhou, Wenchao Lu ORCID, Dangge Wang, Tingting Wang, Cheng Luo, Hao Wang ORCID, Yaping Li, Haijun Yu ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

An oxaliplatin prodrug liposome with an extremely high drug loading ratio (>27%) was reported for treatment of triple-negative breast cancer.